Synoptophore Market - Forecast(2024 - 2030)

Report Code: HCR 1387 Report Format: PDF + Excel

Synoptophore Market Overview

Synoptophore market size was estimated at $220.45 million in 2020, growing at a CAGR of 4.8% during the forecast period 2021-2026. Synoptophore is a device that is used to test binocular vision, measure angles of deviation, and treat binocular aberrations using traditional orthoptic and peptic procedures. It offers standard measurements as well as simple treatments. A conventional Synoptophore is made up of two cylinder tubes with mirrored angle bends in them. Synoptophore's eyepiece is made up of perfect magnification lenses. Picture slides are loaded into the slide transporter at the Synoptophore's tube end. An increasing number of visual acuity disorders including diplopia, amblyopia, strabismus and other disorders is one of the major factors driving the growth of the market. Changing preference of the people from surgical method to non-surgical process in ophthalmic care is set to further enhance the overall market development of the Synoptophore Market for the period 2021-2026.

Report Coverage

The report: Synoptophore Market Forecast (2021-2026), by Industry ARC, covers an in-depth analysis of the following segments of the Synoptophore Market.

By Application: Therapeutic, and Diagnostic
By Type: Automated and Manual
By End-User: Hospitals, Clinics and Others
By Geography: North America (U.S., Canada, Mexico), Europe (Germany, U.K., France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, Japan India, South Korea, Australia, and New Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina, and Rest of South America), and Rest of the World (Middle East, and Africa)

Key Takeaways

  • North America dominated the Synoptophore Market in 2020 owing to increasing incidence of strabismus and amblyopia among the people in this region. The Synoptophore Market scope for different regions will be provided in the final report.
  • Growing technological advancement and research & development activities by market players is set to aid the market growth of the Synoptophore Market report.
  • Detailed analysis of the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Synoptophore Market report.
  • High price of synoptophore is poised to create the hurdles for the Synoptophore Market.

Synoptophore Market Revenue Share, By Geography, 2020(%)

Synoptophore Market Revenue Share
For More Details on This Report - Request for Sample

Synoptophore Market Segment Analysis – By Type

On the basis of type Synoptophore market is categorized in Automated and Manual. Manual category held the largest market share by type in 2020. Manual synoptophore has cheap maintenance costs compare to other and most synoptophore instrument are available in manual form in the market. In some developing nations with price-conscious clients, the manual kind of synoptophore is still in demand thereby increasing Synoptophore market. However, automated is estimated to register higher CAGR of 4.9% during the forecast period 2021-2026 owing to automated synoptophore's capacity to conduct visual acuity test which is quick and efficient while following a consistent protocol and requiring minimal orthoptic intervention.

Synoptophore Market Segment Analysis – By End-User

Based on End User Synoptophore market is segmented into Hospitals, Clinics and Others. Hospitals dominated the market with largest share in 2020. The demand of synoptophore in hospitals is expected to rise as the frequency of emergency patient visits with traumatic brain injury, stroke, and cerebral palsy rises. According to the American Optometric Association, Convergence insufficiency is found in 32% of traumatic brain injury patients. Synoptophore are used for a variety of purposes in such circumstances, ranging from vision therapy during the active rehabilitation stage to a follow-up visual acuity examination during the post-rehabilitation stage. However, clinics is estimated to register higher CAGR of 5.1% during the forecast period 2021-2026 owing to in comparison to hospitals, there is a shorter wait time, better accessibility, and a lower cost.

Synoptophore Market Segment Analysis – By Geography

North America dominated the Synoptophore market with a major share of 43% in 2020. This is attributed to increasing incidence of strabismus and amblyopia in this region. According to the American Academy of Ophthalmology amblyopia affects around 12 million people in the United States. Furthermore, growing awareness about non-invasive technique among the people which are contributing to the growth of the market in this region.

However, Asia Pacific is estimated to grow at a higher CAGR during the forecast period 2021-2026 owing to rising government investment and funding in healthcare sector in this region. Increasing disposable income of the people coupled with rising healthcare expenditure in this region is also increasing the growth of the market in this region.

Synoptophore Market Drivers

Increasing Prevalence of Visual Acuity Disorders

Increasing incidence of visual acuity disorders such as amblyopia, diplopia, strabismus, and others is increasing the growth of the Synoptophore Market. According to the American Academy of Ophthalmology, Amblyopia affects about 1-5% of the world's population. Additionally, increase in awareness about non-invasive techniques is also practiced to increase the growth of the Synoptophore market during the forecast period 2021-2026.

Increasing Technological Advancement

Increasing technological advancement in synoptophore is increasing the growth of the Synoptophore market. Rising research and development activities by key players that helps to development of new treatment for eye problems thereby increasing the growth of the Synoptophore Market during the forecast period 2021-2026. 

Synoptophore Market Challenges

High Cost

Major factor that is set to impede the growth of the Synoptophore market is high of Synoptophore. Another factor which hamper the growth of market is lack of portability of synoptophore. 

Synoptophore Market Landscape

Product launches, mergers and acquisitions, joint ventures, and R&D activities are key strategies adopted by players in the Synoptophore Market. In 2020, the Synoptophore Market share is consolidated by the top ten players present in the market. The Synoptophore Market, top 10 companies are, Shanghai Link Instrument Co. Ltd., Takagi Seiko Co., Ltd, Haag-Streit group, Appasamy Associates, Prkamya Visions, Gem Optical Instruments Industries, Nanjing Redsun Optical Co., Ltd., 66 Vision Tech Co., Ltd., Oculus Optikgerate GmbH, and Huaian Meide Medical Instrument Co., Ltd

Development:

  • In April 2020, Haag-Streit acquired a majority stake in VRmagic, Germany based company. This acquisition will help Haag-Streit to expand its services for ophthalmologists in the crucial area of training. 

Relevant Titles:

Report Code: HCR 0029

Report Code: HCR 0059

For more Lifesciences and Healthcare Market reports, please click here

1. Synoptophore Market - Overview
    1.1 Definitions and Scope
2. Synoptophore Market - Executive Summary
    2.1 Market Revenue and Key Trends
    2.2 Key trends by Application
    2.3 Key trends by Type
    2.4 Key trends by End-User
    2.5 Key trends by Geography
3. Synoptophore Market – Comparative Analysis
    3.1 Product Benchmarking – Key Companies
    3.2 Financial Analysis – Key Companies
    3.3 Market Value Split by Key Companies
    3.4 Patent Analysis
    3.5 Pricing Analysis- Average Selling Price
4. Synoptophore Market - Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Synoptophore Market – Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Synoptophore Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Synoptophore Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Synoptophore Market – By Application(Market Size –$Million/$Billion)
    8.1 Therapeutic
    8.2 Diagnostic
9. Synoptophore Market - By Type (Market Size –$Million/$Billion)
    9.1 Automated
    9.2 Manual
10. Synoptophore Market - By End-User(Market Size –$Million/$Billion)
    10.1 Hospitals
    10.2 Clinics
    10.3 Others
11. Synoptophore Market - By Geography(Market Size –$Million/$Billion)
    11.1 North America
        11.1.1 U.S.
        11.1.2 Mexico
        11.1.3 Canada
    11.2 Europe
        11.2.1 U.K.
        11.2.2 France
        11.2.3 Germany
        11.2.4 Italy
        11.2.5 Spain
        11.2.6 Russia
        11.2.7 Rest of Europe
    11.3 Asia Pacific
        11.3.1 China
        11.3.2 India
        11.3.3 Japan
        11.3.4 South Korea
        11.3.5 Australia & New Zealand
        11.3.6 Rest of APAC
    11.4 South America
        11.4.1 Brazil
        11.4.2 Argentina
        11.4.3 Others
    11.5 Rest of the World
        11.5.1 Middle East
        11.5.2 Africa
12. Synoptophore Market - Entropy
13. Synoptophore Market – Industry/Segment Competition Landscape Premium
    13.1 Market Share Analysis
        13.1.1 Global Market Share – Key Companies
        13.1.2 Market Share by Region – Key companies
        13.1.3 Market Share by Countries – Key Companies
        13.1.4 Competition Matrix
        13.1.5 Best Practices for Companies
14. Synoptophore Market – Key Company List by Country Premium Premium
15. Synoptophore Market Company Analysis Analysis(Company Revenue, Product, M&A, Developments)
    15.1 Company 1
    15.2 Company 2
    15.3 Company 3
    15.4 Company 4
    15.5 Company 5
    15.6 Company 6
    15.7 Company 7
    15.8 Company 8
    15.9 Company 9
    15.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.